What is the recommended treatment for a patient with a urinary tract infection caused by Enterococcus faecalis, given the results of the urine culture and antimicrobial susceptibility testing?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Enterococcus faecalis Urinary Tract Infection

For a urinary tract infection caused by Enterococcus faecalis with the provided susceptibility results, penicillin or nitrofurantoin is the recommended first-line treatment due to demonstrated susceptibility and established clinical efficacy.

Interpretation of Culture Results

The urine culture shows:

  • Organism: Enterococcus faecalis
  • Colony count: >100,000 CFU/mL (significant bacteriuria)
  • Susceptibility profile:
    • Susceptible: Ciprofloxacin, Levofloxacin, Nitrofurantoin, Penicillin, Vancomycin
    • Resistant: Tetracycline

Treatment Algorithm

First-line options (based on susceptibility and guidelines):

  1. Uncomplicated UTI (cystitis):

    • Nitrofurantoin 100 mg PO every 6 hours for 5 days 1
    • Penicillin derivatives:
      • Ampicillin 500 mg PO every 8 hours for 5-7 days
      • Amoxicillin 500 mg PO every 8 hours for 5-7 days
  2. Complicated UTI or pyelonephritis:

    • Ampicillin 1-2 g IV every 6 hours for 7-14 days
    • Penicillin G 2-4 million units IV every 4-6 hours for 7-14 days

Alternative options (if first-line cannot be used):

  • Fluoroquinolones (based on susceptibility):

    • Ciprofloxacin 500 mg PO twice daily for 7 days
    • Levofloxacin 500 mg PO daily for 7 days
  • Vancomycin (reserve for serious infections or when other options cannot be used):

    • 15-20 mg/kg IV every 12 hours (adjusted based on renal function)

Rationale for Treatment Selection

  1. Penicillin/Ampicillin: Enterococci susceptible to penicillin are predictably susceptible to ampicillin, amoxicillin, and other beta-lactams as noted in the culture report. These are considered first-line therapy for enterococcal infections 1.

  2. Nitrofurantoin: Highly effective for uncomplicated UTIs caused by E. faecalis with excellent urinary concentrations and low resistance rates 1, 2. The culture shows susceptibility to nitrofurantoin.

  3. Fluoroquinolones: While the organism is susceptible to ciprofloxacin and levofloxacin, these should be reserved as alternatives due to concerns about promoting resistance and ecological adverse effects 1.

Special Considerations

  • Avoid cephalosporins, clindamycin, and trimethoprim-sulfamethoxazole: As noted in the culture report, these are not effective against Enterococcus species even if reported as susceptible 1.

  • Duration of therapy:

    • Uncomplicated cystitis: 5 days
    • Complicated UTI or pyelonephritis: 7-14 days
  • Follow-up: Routine post-treatment urinalysis or urine cultures are not indicated for asymptomatic patients 1. Only repeat cultures if symptoms persist or recur within 2 weeks of treatment completion.

Pitfalls to Avoid

  1. Using tetracycline: The isolate is resistant to tetracycline and should not be used.

  2. Using aminoglycosides as monotherapy: Enterococci have intrinsic low-level resistance to aminoglycosides, making them ineffective as single agents 1.

  3. Treating asymptomatic bacteriuria: Unless the patient is pregnant or undergoing urologic procedures, asymptomatic bacteriuria with enterococci generally does not require treatment 3.

  4. Failing to assess for complicated UTI: E. faecalis UTIs are associated with higher rates of anatomical abnormalities, especially in children 4. Consider imaging if recurrent infections occur.

  5. Overlooking catheter removal: If a urinary catheter is present, removal or replacement should be considered as part of the management strategy 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of resistant enterococcal urinary tract infections.

Current infectious disease reports, 2010

Research

Community-acquired enterococcal urinary tract infections.

Pediatric nephrology (Berlin, Germany), 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.